Literature DB >> 10471611

Interleukin-18 enhances antigen-induced eosinophil recruitment into the mouse airways.

K Kumano1, A Nakao, H Nakajima, F Hayashi, M Kurimoto, H Okamura, Y Saito, I Iwamoto.   

Abstract

Interleukin-18 (IL-18) has recently been identified as an IFN-gamma-inducing factor. Previous studies have shown that CD4(+) T cells, IL-5, and TNF-alpha mediate, but IFN-gamma and IL-12 (via IFN-gamma production) inhibit antigen-induced eosinophil recruitment into the airways of sensitized mice. Here, we showed that the administration of recombinant murine IL-18 enhanced antigen-induced eosinophil recruitment into the trachea and bronchoalveolar lavage fluids (BALF) of sensitized mice in a dose-dependent manner. The administration of IL-18 enhanced antigen-induced IFN-gamma and TNF-alpha production, but not IL-5 production, in the BALF and lungs of sensitized mice. Neutralizing antibody against TNF-alpha prevented antigen-induced eosinophil recruitment into the BALF of sensitized mice. Although IL-18 enhanced antigen-induced airway eosinophilia, IL-18 did not affect antigen-induced airway hyperresponsiveness in sensitized mice. These results indicate that IL-18, unlike IFN-gamma and IL-12, enhances antigen-induced eosinophil recruitment into the airways in part by increasing antigen-induced TNF-alpha production of sensitized animals. These findings suggest that IL-18 may contribute to the development and exacerbation of airway inflammation in asthma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471611     DOI: 10.1164/ajrccm.160.3.9805026

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  16 in total

1.  IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway.

Authors:  Kelly M Kroeger; Brandon M Sullivan; Richard M Locksley
Journal:  J Leukoc Biol       Date:  2009-05-18       Impact factor: 4.962

2.  Multiple interleukin-18 injections promote both mouse Th1 and Th2 responses after sublethal Escherichia coli infection.

Authors:  M Kinoshita; N Kuranaga; A Matsumoto; S Ono; N Shinomiya; H Hiraide; S Seki
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

3.  Eosinophils are recruited in response to chitin exposure and enhance Th2-mediated immune pathology in Aspergillus fumigatus infection.

Authors:  Evan M O'Dea; Nansalmaa Amarsaikhan; Hongtao Li; Joshua Downey; Emery Steele; Steven J Van Dyken; Richard M Locksley; Steven P Templeton
Journal:  Infect Immun       Date:  2014-05-19       Impact factor: 3.441

Review 4.  Synergy of Interleukin (IL)-5 and IL-18 in eosinophil mediated pathogenesis of allergic diseases.

Authors:  Hemanth Kumar Kandikattu; Sathisha Upparahalli Venkateshaiah; Anil Mishra
Journal:  Cytokine Growth Factor Rev       Date:  2019-05-10       Impact factor: 7.638

5.  Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma.

Authors:  C K Wong; C Y Ho; F W Ko; C H Chan; A S Ho; D S Hui; C W Lam
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

6.  IL-2 and IL-18 attenuation of airway hyperresponsiveness requires STAT4, IFN-gamma, and natural killer cells.

Authors:  Shigeki Matsubara; Katsuyuki Takeda; Taku Kodama; Anthony Joetham; Nobuaki Miyahara; Toshiyuki Koya; Christina H Swasey; Masakazu Okamoto; Azzeddine Dakhama; Erwin W Gelfand
Journal:  Am J Respir Cell Mol Biol       Date:  2006-10-12       Impact factor: 6.914

7.  Immunoglobulin e, interleukin-18 and interleukin-12 in patients with atopic dermatitis: correlation with disease activity.

Authors:  Khaled Zedan; Zafar Rasheed; Yaser Farouk; Abdullateef A Alzolibani; Ghada Bin Saif; Hisham A Ismail; Ahmad A Al Robaee
Journal:  J Clin Diagn Res       Date:  2015-04-01

8.  Aberrant expression of CC and CXC chemokines and their receptors in patients with asthma.

Authors:  Samantha W M Lun; C K Wong; Fanny W S Ko; W K Ip; David S C Hui; Christopher W K Lam
Journal:  J Clin Immunol       Date:  2006-04-07       Impact factor: 8.317

9.  Serum interleukin-18 and soluble tumour necrosis factor receptor 2 are associated with disease severity in patients with paracoccidioidomycosis.

Authors:  C L Corvino; R L Mamoni; G Z Z Fagundes; M H S L Blotta
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

10.  The effect of interleukin-18 on airway inflammation in asthmatic murine models and its mechanisms.

Authors:  Huilan Zhang; Zhenxiang Zhang; Yongjian Xu; Lihua Xing; Jianbo Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.